中国省级药品监管绩效评价初步研究

doi:10.5246/jcps.2013.06.073

中国省级药品监管绩效评价初步研究

全铭, 杨松, 李妍嫣, 侯志忺, 江滨^*

1. 北京大学医学部药学院药事管理与临床药学系, 北京 100191
2. 北京润美康医药有限公司, 北京 100738

收稿日期:2012-02-25 修回日期:2013-04-30 出版日期:2013-11-15 发布日期:2014-01-22
通讯作者: 江滨*

Exploratory study on performance evaluation of drug administration at
provincial level in China

Ming Quan, Song Yang, Yanyan Li, Zhixian Hou, Bin Jiang*

1. Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
2. Beijing Medi'Care Co. Ltd., Beijing 100738, China

Received:2012-02-25 Revised:2013-04-30 Online:2013-11-15 Published:2014-01-22
Contact: Bin Jiang*

摘要/Abstract

摘要：

为构建科学可靠的评价中国各省药品监管工作绩效的指标体系, 本研究在借鉴政府绩效评价理论和国内外医药卫生绩效评价实践等相关文献的基础上, 结合实地调查、关键人物访谈、模糊综合评价、多次Delphi等方法, 构建了“投入-过程-结果”三维评价指标体系。通过层次分析法进行指标权重赋值, 采用《2010年食品药品监管统计年鉴》、《中国2010年统计年鉴》的数据, 对我国30省 (西藏的数据不可得)的药品监管绩效进行了评价和排名。测算结果得到了国家和省级药品部门的认可, 表明采用本研究构建的“投入-过程-结果”三维评价指标体系测算我国各省的药品监管绩效是可行的。

关键词: 药品监管, 绩效评价, 指标体系, 投入-过程-结果

Abstract:

To construct a reliable indicator system to evaluate drug administration performance at provincial level in China, we referred to theories on government performance evaluation and practice of health performance evaluation, conducted field investigation, key person interview, fuzzy comprehensive evaluation and multi-round Delphi to build a three-dimensional evaluation indicator system of “input-process-outcome”. Weight of indicators was determined by the analytic hierarchy process (AHP). The related data were from Food and Drug Administration Statistical Yearbook for 2010 and China Statistical Yearbook for 2010. Thirty provinces were included in the rankings except Tibet for the unavailability of data. The ranking was highly accepted by officials from central and provincial drug administration agencies, which indicated the three-dimensional evaluation indicator system is feasible to assess drug administration performance at provincial level in China.

Key words: Drug administration, Performance evaluation, Indicator system, Input-process-outcome

中图分类号:

R954

Supporting:

^*Corresponding author. Tel.: 13601100121

全铭, 杨松, 李妍嫣, 侯志忺, 江滨^*. 中国省级药品监管绩效评价初步研究 [J]. , DOI: 10.5246/jcps.2013.06.073.

Ming Quan, Song Yang, Yanyan Li, Zhixian Hou, Bin Jiang* . Exploratory study on performance evaluation of drug administration at
provincial level in China [J]. , DOI: 10.5246/jcps.2013.06.073.

参考文献

[1] Yang, C.F.; Liu, L.M.; Dong, Y.G. Chin. J. Heal. Insp. 2011, 18, 128-129.
[2] Yang, S.J. Gansu Soc. Sci. 2005, 6, 239-240.
[3] Zhang, M. Ph.D. thesis, Shaanxi University. 2008.
[4] Liu, Y.J. Ph.D. thesis, Huazhong University of Science and Technology. 2009.
[5] WHO. Indicators for Monitoring National Drug Policies. Geneva: WHO. 1999, 108.
[6] WHO. How to Investigate Drug Use in Health Facilities. Geneva: WHO. 1993, 35.
[7] WHO. Measuring Medicine Prices, Availability, Affordability and Price Components. Geneva: WHO. 2003, 22.
[8] Jing, Z. China Pub. Admin. 2003, 3, 12-13.
[9] Guo, Q.; Wang, S.; Wang, X.H. Chin. General Prac. 2002, 5, 888-889.
[10] Hu, M.; Chen, Q.J.; Wu, P. Chin. Pharm. 2010, 21, 685-687.
[11] Du, J.L.; Li, Y.Y.; Chen, X.M. Henan J. Prev. Med. 2007, 18, 82-84.
[12] GAO. FDA Faces Challenges Meeting its Growing Medical Product Responsibilities and Should Develop Complete Estimates of its Resource Needs. Washington: GAO. 2009, 17.
[13] GAO. Comprehensive Assessment of Staffing, Facilities and Equipment Needs. Washington: GAO. 1989, 9.
[14] GAO. Opportunities Exist to better Address Management Challenges. Washington: GAO. 2010, 6.
[15] Hu, Y.L. J. Pub. Admin. 2011, 2, 70-94.
[16] GAO. Challenges for FDA in Conducting Manufacturer Inspections. Washington: GAO. 2008, 11.
[17] GAO. Better Data Management and more Inspections are Needed to Strengthen FDA’s Foreign Drug Inspection Program. Washington: GAO. 2008, 15.
[18] GAO. FDA’s Food Advisory and Recall Process Needs Strengthening. Washington: GAO. 2012, 22.
[19] GAO. FDA’s Premarket Review and Post Market Safety Efforts. Washington: GAO. 2011, 5.
[20] Peng, G.F.; Li, D.C.; Sheng, M.K. China Soft Sci. 2004, 6, 136-139.
[21] Saaty, Thomas. Decision Making for Leaders: the Analytic Hierarchy Process for Decisions in a Complex World. PA: RWS Publications. 1990, 29.
[22] Wu, S.L.; Lv, J.; Guo, S.L. Sci. Sci. Magmt. S&T. 2010, 4, 7-13.